SAKATA SHINYA 坂田晋也

… Alternative Names

坂田晋也サカタシンヤ

Less

Researcher Number	60794451
Other IDs
Affiliation (Current)	2025: 熊本大学, 病院, 特任助教
Affiliation (based on the past Project Information) *help	2025: 熊本大学, 病院, 特任助教 2020 – 2023: 熊本大学, 病院, 特任助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator 免疫チェックポイント阻害薬 / 悪性胸膜中皮腫 / CBM588 / PBMC / 末梢血免疫サブセット解析 / 肺癌 / 放射線治療 / ICDマーカー解析 / 免疫サブセット解析 / 末梢血単核球細胞

Development of a Novel Gut Microbiota-Targeted Therapy for Malignant Pleural MesotheliomaPrincipal Investigator
- Principal Investigator
  
  坂田晋也
- Project Period (FY)
  2025 – 2029
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kumamoto University
肺癌に対する放射線療法と免疫療法の有効性の関連解析および最適な治療法の開発Principal Investigator
- Principal Investigator
  
  坂田晋也
- Project Period (FY)
  2020 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kumamoto University

All 2023 2022 2021 2020

All Journal Article

[Journal Article] Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations2023
- Author(s)
  Tomiya Y, Sakata S, Imamura K, Iyama S, Jodai T, et al.
- Journal Title
  
  Cancers
  
  Volume: 16 Issue: 1 Pages: 47-47
- DOI
  10.3390/cancers16010047
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K16449, KAKENHI-PROJECT-22KK0277, KAKENHI-PROJECT-22K08256, KAKENHI-PROJECT-21K08494, KAKENHI-PROJECT-18K15928, KAKENHI-PROJECT-21H02788, KAKENHI-PROJECT-23K24139
[Journal Article] Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer2022
- Author(s)
  Imamura Kosuke、Tomita Yusuke、Sato Ryo、Ikeda Tokunori、Iyama Shinji、Jodai Takayuki、Takahashi Misako、Takaki Akira、Akaike Kimitaka、Hamada Shohei、Sakata Shinya、Saruwatari Koichi、Saeki Sho、Ikeda Koei、Suzuki Makoto、Sakagami Takuro
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 23 Issue: 22 Pages: 13723-13723
- DOI
  10.3390/ijms232213723
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08256, KAKENHI-PROJECT-18K15928, KAKENHI-PROJECT-20K16449
[Journal Article] Histologic transformation of epidermal growth factor receptor-mutated lung cancer2022
- Author(s)
  Fujimoto D, Akamatsu H, Morimoto T, Wakuda K, Sakata S, Yamamoto N, et al.
- Journal Title
  
  Eur J Cancer
  
  Volume: 166 Pages: 41-50
- DOI
  10.1016/j.ejca.2022.02.006
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16449
[Journal Article] Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L.2022
- Author(s)
  Sakata S, Otsubo K, Yoshida H, Ito K, Nakamura A, Teraoka S, Matsumoto N, Shiraishi Y, Haratani K, Tamiya M, Ikeda S, Miura S, Tanizaki J, Omori S, Yoshioka H, Hata A, Yamamoto N, Nakagawa K.
- Journal Title
  
  Cancer Science
  
  Volume: 113 Issue: 1 Pages: 221-228
- DOI
  10.1111/cas.15176
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K16449
[Journal Article] Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors2022
- Author(s)
  Tomita Yusuke、Goto Yoshihiko、Sakata Shinya、Imamura Kosuke、Minemura Ayaka、Oka Kentaro、Hayashi Atsushi、Jodai Takayuki、Akaike Kimitaka、Anai Moriyasu、Hamada Shohei、Iyama Shinji、Saruwatari Koichi、Saeki Sho、Takahashi Motomichi、Ikeda Tokunori、Sakagami Takuro
- Journal Title
  
  OncoImmunology
  
  Volume: 11 Issue: 1 Pages: 2081010-2081010
- DOI
  10.1080/2162402x.2022.2081010
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08256, KAKENHI-PROJECT-18K15928, KAKENHI-PROJECT-20K16449
[Journal Article] Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT).2021
- Author(s)
  Sakata Y, Sakata S, Oya Y, Tamiya M, Suzuki H, Shibaki R, Okada A, Kobe H, Matsumoto H, Yokoi T, Sato Y, Uenami T, Saito G, Tsukita Y, Inaba M, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Morinaga J, Sakagami T.
- Journal Title
  
  European Journal of Cancer
  
  Volume: 159 Pages: 144-153
- DOI
  10.1016/j.ejca.2021.09.041
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16449
[Journal Article] Heterogeneous tumor‐immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti‐PD‐L1 antibody therapy2020
- Author(s)
  Sakata Shinya、Imamura Kosuke、Tajima Yuka、Masuda Yuiko、Sato Ryo、Yoshida Chieko、Okamoto Shinichiro、Saeki Sho、Tomita Yusuke、Sakagami Takuro
- Journal Title
  
  Thoracic Cancer
  
  Volume: 12 Issue: 3 Pages: 397-401
- DOI
  10.1111/1759-7714.13772
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15928, KAKENHI-PROJECT-20K16449
[Journal Article] Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer2020
- Author(s)
  Tomita Yusuke、Ikeda Tokunori、Sakata Shinya、Saruwatari Koichi、Sato Ryo、Iyama Shinji、Jodai Takayuki、Akaike Kimitaka、Ishizuka Shiho、Saeki Sho、Sakagami Takuro
- Journal Title
  
  Cancer Immunology Research
  
  Volume: 8 Issue: 10 Pages: 1236-1242
- DOI
  10.1158/2326-6066.cir-20-0051
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K15928, KAKENHI-PROJECT-20K16449

1. 池田徳典

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
2. 冨田雄介

# of Collaborated Projects: 0 results

# of Collaborated Products: 4 results

SAKATA SHINYA 坂田 晋也

坂田 晋也 サカタ シンヤ

Research Projects

Research Products

Co-Researchers

Development of a Novel Gut Microbiota-Targeted Therapy for Malignant Pleural MesotheliomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

肺癌に対する放射線療法と免疫療法の有効性の関連解析および最適な治療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Histologic transformation of epidermal growth factor receptor-mutated lung cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT).2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Heterogeneous tumor‐immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti‐PD‐L1 antibody therapy2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer2020

Author(s)

Journal Title

DOI

Data Source

SAKATA SHINYA 坂田晋也

坂田晋也サカタシンヤ